Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study.

Yuan, Hsinsung; Zhu, Xiao; Luo, Qiang; Halim, Alice; Halim, Michael; Yao, Hao; Cai, Yiyun; Shi, Shenxun

Yuan, Hsinsung; Zhu, Xiao; Luo, Qiang; Halim, Alice; Halim, Michael; Yao, Hao; Cai, Yiyun; Shi, Shenxun.

Afiliación

Yuan H; Psychiatry Department of Huashan Hospital, Fudan University, Shanghai, People's Republic of China, shishenxun@163.com.
Zhu X; Psychiatry Department of Nanjing Brain Hospital, Nanjing, People's Republic of China.
Luo Q; Psychiatry Department of Huashan Hospital, Fudan University, Shanghai, People's Republic of China, shishenxun@163.com.
Halim A; Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, People's Republic of China.
Halim M; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (Ministry of Education), Fudan University, Shanghai, People's Republic of China.
Yao H; Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Cai Y; Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Shi S; Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.

Neuropsychiatr Dis Treat ; 15: 957-966, 2019.

Article en En | MEDLINE | ID: mdl-31354272

Palabras clave

antidepressants; early improvement; major depressive disorder; selective serotonin reuptake inhibitors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neuropsychiatr Dis Treat Año: 2019 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google